ES2098543T3 - Un proceso para la purificacion de extractos acuosos que contienen proteinas alergenicamente activas, extractos obtenibles de acuerdo con este proceso, asi como su uso. - Google Patents

Un proceso para la purificacion de extractos acuosos que contienen proteinas alergenicamente activas, extractos obtenibles de acuerdo con este proceso, asi como su uso.

Info

Publication number
ES2098543T3
ES2098543T3 ES92920684T ES92920684T ES2098543T3 ES 2098543 T3 ES2098543 T3 ES 2098543T3 ES 92920684 T ES92920684 T ES 92920684T ES 92920684 T ES92920684 T ES 92920684T ES 2098543 T3 ES2098543 T3 ES 2098543T3
Authority
ES
Spain
Prior art keywords
pct
allergenic
molecular weight
proteins
low
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92920684T
Other languages
English (en)
Inventor
Lubertus Berrens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Leti SA
CBF Leti SA
Original Assignee
Laboratorios Leti SA
CBF Leti SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Leti SA, CBF Leti SA filed Critical Laboratorios Leti SA
Priority claimed from CA002145169A external-priority patent/CA2145169C/en
Application granted granted Critical
Publication of ES2098543T3 publication Critical patent/ES2098543T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

EL INVENTO SE REFIERE A LA ELIMINACION DE DIVERSOS COMPONENTES DE BAJO PESO MOLECULAR ALERGOLOGICAMENTE IRRELEVANTES DE LOS EXTRACTOS ACUOSOS USUALES EN PROTEINAS ALERGENICAMENTE ACTIVAS DE POLEN DE PLANTAS. SE DESCRIBE LA DESORCION Y ELIMINACION SUBSECUENTE, DESDE EXTRACTOS DE PROTEINAS DE POLEN ALERGENICO PREPARADOS TRADICIONALMENTE, DE PIGMENTOS DE BAJO PESO MOLECULAR Y OTROS COMPUESTOS QUE NORMALMENTE SE RETIENEN POR PODEROSAS FUERZAS ELECTROSTATICA Y/O HIDROFOBICA. LA PREPARACION DE TALES PROTEINAS DE POLEN DEPIGMENTADO NO DISMINUYE SU POTENCIA ALERGENICA O SU ESPECIFICIDAD INMUNOLOGICA. EL INVENTO POSIBILITA LA PRODUCCION DE PROTEINAS DE POLEN ALERGENICO TOTALMENTE ACTIVO DESPROVISTAS DE ADHESION DE SUBSTANCIAS DE BAJO PESO MOLECULAR QUE INTERFIEREN CON SU SEGURIDAD, PRECISION DIAGNOSTICA Y EFICACIA CLINICA. LAS PROTEINAS DE POLEN PURIFICADO REPRESENTAN MATERIALES DE INICIO MEJORADOS POR DERIVACION QUIMICA, ES DECIR, LA PREPARACION DE VACUNAS ATENUADAS DE INMUNOTERAPIA. EL INVENTO TAMBIEN PROPORCIONA PRODUCTOS APROPIADOS PARA LA INVESTIGACION DE LA ESTRUCTURA MOLECULAR DE EPITOPES ALERGENICOS.
ES92920684T 1992-09-21 1992-09-21 Un proceso para la purificacion de extractos acuosos que contienen proteinas alergenicamente activas, extractos obtenibles de acuerdo con este proceso, asi como su uso. Expired - Lifetime ES2098543T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002145169A CA2145169C (en) 1992-09-21 1992-09-21 A process for the purification of aqueous extracts containing allergenically active proteins, extracts obtainable according to this process as well as their use
PCT/NL1992/000160 WO1994006821A1 (en) 1992-09-21 1992-09-21 A process for the purification of aqueous extracts containing allergenically active proteins, extracts obtainable according to this process as well as their use

Publications (1)

Publication Number Publication Date
ES2098543T3 true ES2098543T3 (es) 1997-05-01

Family

ID=4155482

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92920684T Expired - Lifetime ES2098543T3 (es) 1992-09-21 1992-09-21 Un proceso para la purificacion de extractos acuosos que contienen proteinas alergenicamente activas, extractos obtenibles de acuerdo con este proceso, asi como su uso.

Country Status (6)

Country Link
US (1) US5770698A (es)
EP (1) EP0662080B1 (es)
AT (1) ATE148708T1 (es)
AU (1) AU675629B2 (es)
DE (3) DE69217395T2 (es)
ES (1) ES2098543T3 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6350590B1 (en) * 1997-10-30 2002-02-26 C.B.F. Leti, S.A. Tolerogenic fragments of natural allergens
US6562630B2 (en) * 2000-10-12 2003-05-13 Thomas H. Bryant Method for preparation and use of preservative-free immunoassay reagents
IL139308A0 (en) * 2000-10-26 2001-11-25 Marikovsky Moshe Peptides from amyloid precursor protein which inhibit tumor growth and metastasis
SE0004891D0 (sv) * 2000-12-29 2000-12-29 Pharmacia Diagnostics Ab Use of a pure allergen component
US20060269576A1 (en) * 2005-05-27 2006-11-30 Curalogic, A/S Non-injection immunotherapy
EP1872792A1 (en) 2006-06-29 2008-01-02 Biotech Tools S.A. A method for the production of hydrolyzed allergen
KR100828107B1 (ko) * 2006-09-29 2008-05-08 주식회사 코스트리 저백피 추출물을 함유하는 화장료 조성물
US20100278880A1 (en) * 2008-01-02 2010-11-04 Biotech Tools S.A. Pharmaceutical formulation for allergen preparation
EP2258391A1 (en) * 2009-06-05 2010-12-08 Stallergenes S.A. Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids
RU2572230C2 (ru) 2010-02-12 2015-12-27 Лабораториос Лети, С.Л. Способ получения экстракта аллергена
US9175052B2 (en) 2013-05-17 2015-11-03 R.J. Reynolds Tobacco Company Tobacco-derived protein compositions
EP2974741A1 (en) * 2014-07-16 2016-01-20 Stallergenes Composition of allergen extracts having reduced toxicity and method of production thereof
FR3049866B1 (fr) 2016-04-07 2019-09-06 Nfl Biosciences Extrait de feuilles de tabac et utilisation pour le traitement de l'addiction au tabac
JP2019530702A (ja) 2016-10-05 2019-10-24 アシット バイオテック エスエー アレルギーの予防
US11408895B1 (en) 2018-04-09 2022-08-09 Hob Biotech Group Corp., Ltd. Allergen characterization, potent allergen product formulation, comprehensive allergen reagent, and allergy assay
US11617789B2 (en) 2018-11-09 2023-04-04 Jubilant HollisterStier LLC Process for the preparation of allergenic extracts
CR20210432A (es) 2019-01-17 2022-01-05 Leti Pharma S L Métodos para purificar un extracto de alérgeno
IT202200011459A1 (it) * 2022-05-31 2023-12-01 Anallergo S P A Uso della ultrafiltrazione per la produzione di estratti allergenici purificati
WO2024089465A2 (en) 2022-10-24 2024-05-02 Nfl Biosciences Methods of treatment involving tobacco leaf extracts to help smoking cessation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8900652A (nl) * 1989-03-16 1990-10-16 Leti Lab Primair-toxische stoffen of allergenen, isoleerbaar uit plantaardig materiaal, alsmede werkwijzen ter bereiding ervan en de toepassing ervan.

Also Published As

Publication number Publication date
US5770698A (en) 1998-06-23
EP0662080B1 (en) 1997-02-05
DE69217395D1 (de) 1997-03-20
DE122005000034I1 (de) 2005-10-20
AU2648692A (en) 1994-04-12
DE122005000035I1 (de) 2005-10-20
ATE148708T1 (de) 1997-02-15
DE122005000035I2 (de) 2008-03-27
DE69217395T2 (de) 1997-05-22
AU675629B2 (en) 1997-02-13
EP0662080A1 (en) 1995-07-12

Similar Documents

Publication Publication Date Title
ES2098543T3 (es) Un proceso para la purificacion de extractos acuosos que contienen proteinas alergenicamente activas, extractos obtenibles de acuerdo con este proceso, asi como su uso.
DE69032806T2 (de) Verfahren zur isolierung und reinigung von rezeptoren für transferrin und lactoferrin von bakterien und herstellung von impfstoffen, die sie enthalten
EP0814089A3 (en) Respiratory syncytial virus: vaccines and diagnostic assays
NO900031L (no) Fremgangsmaate for fremstilling av olefiner ut fra naturgass.
EP0339237A3 (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them
DE59303142D1 (de) Süssungsmittel, Verfahren zur Herstellung desselben sowie dessen Verwendung
NO891388D0 (no) Fremgangsmaate for fremstilling av olefiner ut fra naturgass.
AR240990A1 (es) Procedimiento para la separacion de moleculas de interes biologico,de una mezcla que las contiene."
WO1999038528A3 (de) Vakzineformulierungen
CA2050910A1 (en) Human intra-acrosomal sperm antigen for use in a contraceptive vaccine
EP0160260A3 (de) Verfahren zur Immobilisierung von biologischem Material
CA2145169A1 (en) A process for the purification of aqueous extracts containing allergenically active proteins, extracts obtainable according to this process as well as their use
DE69738770D1 (de) Porphyromonas gingivalis Antigene zur Diagnose und Behandlung von Periodontitis
FI913454A0 (fi) Menetelmä sellaisen glykosfingolipidien seoksen valmistamiseksi ja puhdistamiseksi, joka on vapaa ei-tavanomaisten virusten aiheuttamista epäpuhtauksista
BR0212260A (pt) Agente antimicrobiano
DE69101537D1 (de) Verfahren zur Herstellung von Chloroform aus Kohlenstofftetrachlorid, katalytische Zusammensetzungen sowie Verfahren zu ihrer Herstellung.
DK0474645T3 (da) Proteinkompleks
DE69013132T2 (de) Verfahren zur Herstellung von Octa-2,7-dien-1-ol.
SE9002674L (sv) Foerfarande foer framstaellning av hoegrenad fosfatidylinositol
Moura-da-Silva et al. Neutralization of myotoxic activity of Bothrops venoms by antisera to purified myotoxins and to crude venoms
DE69013621T2 (de) Verfahren zur Herstellung von tertiärem Amino-Alkohol.
DE68921722D1 (de) Verfahren zur Herstellung von DL-Serin, und Verfahren zu dessen Trennung und Reinigung.
FI902814A0 (fi) Proteiner, vaccin och nukleinsyror.
DE69026912T2 (de) Verfahren zur Herstellung von Nojirimycin-Verbindungen
Galikeev et al. Case of isolation of the influenza virus B from the nasopharynx of a healthy human being

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 662080

Country of ref document: ES